217 related articles for article (PubMed ID: 28327908)
61. Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.
Holowatyj AN; Ose J; Gigic B; Lin T; Ulvik A; Geijsen AJMR; Brezina S; Kiblawi R; van Roekel EH; Baierl A; Böhm J; Bours MJL; Brenner H; Breukink SO; Chang-Claude J; de Wilt JHW; Grady WM; Grünberger T; Gumpenberger T; Herpel E; Hoffmeister M; Keulen ETP; Kok DE; Koole JL; Kosma K; Kouwenhoven EA; Kvalheim G; Li CI; Schirmacher P; Schrotz-King P; Singer MC; van Duijnhoven FJB; van Halteren HK; Vickers K; Vogelaar FJ; Warby CA; Wesselink E; Ueland PM; Ulrich AB; Schneider M; Habermann N; Kampman E; Weijenberg MP; Gsur A; Ulrich CM
Am J Clin Nutr; 2022 Aug; 116(2):303-313. PubMed ID: 35394006
[TBL] [Abstract][Full Text] [Related]
62. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
[TBL] [Abstract][Full Text] [Related]
63. The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance).
Cheng E; Zhang S; Ou FS; Mullen B; Ng K; Saltz LB; Niedzwiecki D; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Meyerhardt JA; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1692-1695. PubMed ID: 32499312
[TBL] [Abstract][Full Text] [Related]
64. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
Fedirko V; Riboli E; Tjønneland A; Ferrari P; Olsen A; Bueno-de-Mesquita HB; van Duijnhoven FJ; Norat T; Jansen EH; Dahm CC; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Lukanova A; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Benetou V; Trichopoulos D; Grioni S; Vineis P; Panico S; Palli D; Tumino R; Siersema PD; Peeters PH; Skeie G; Brustad M; Chirlaque MD; Barricarte A; Ramón Quirós J; Sánchez MJ; Dorronsoro M; Bonet C; Palmqvist R; Hallmans G; Key TJ; Crowe F; Khaw KT; Wareham N; Romieu I; McKay J; Wark PA; Romaguera D; Jenab M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):582-93. PubMed ID: 22278364
[TBL] [Abstract][Full Text] [Related]
65. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.
Wilkinson NW; Yothers G; Lopa S; Costantino JP; Petrelli NJ; Wolmark N
Ann Surg Oncol; 2010 Apr; 17(4):959-66. PubMed ID: 20082144
[TBL] [Abstract][Full Text] [Related]
66. ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy.
Li P; Fang YJ; Li F; Ou QJ; Chen G; Ma G
Br J Cancer; 2013 Apr; 108(6):1238-44. PubMed ID: 23481186
[TBL] [Abstract][Full Text] [Related]
67. Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.
Meyerhardt JA; Catalano PJ; Schrag D; Ayanian JZ; Haller DG; Mayer RJ; Macdonald JS; Benson AB; Fuchs CS
Ann Intern Med; 2003 Oct; 139(8):649-57. PubMed ID: 14568853
[TBL] [Abstract][Full Text] [Related]
68. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Warren RS; Atreya CE; Niedzwiecki D; Weinberg VK; Donner DB; Mayer RJ; Goldberg RM; Compton CC; Zuraek MB; Ye C; Saltz LB; Bertagnolli MM
Clin Cancer Res; 2013 Oct; 19(20):5777-87. PubMed ID: 23983256
[TBL] [Abstract][Full Text] [Related]
69. Predicted Vitamin D Status and Colorectal Cancer Incidence in the Black Women's Health Study.
Barber LE; Bertrand KA; Petrick JL; Gerlovin H; White LF; Adams-Campbell LL; Rosenberg L; Roy HK; Palmer JR
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2334-2341. PubMed ID: 34620630
[TBL] [Abstract][Full Text] [Related]
70. Influence of genetic variation in the vitamin D pathway on plasma 25-hydroxyvitamin D
Yuan C; Renfro L; Ambadwar PB; Ou FS; McLeod HL; Innocenti F; Meyerhardt JA; Wolpin BM; Goldberg RM; Grothey A; Fuchs CS; Ng K
Cancer Causes Control; 2019 Jul; 30(7):757-765. PubMed ID: 31104167
[TBL] [Abstract][Full Text] [Related]
71. PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.
Ogino S; Nosho K; Kirkner GJ; Shima K; Irahara N; Kure S; Chan AT; Engelman JA; Kraft P; Cantley LC; Giovannucci EL; Fuchs CS
J Clin Oncol; 2009 Mar; 27(9):1477-84. PubMed ID: 19237633
[TBL] [Abstract][Full Text] [Related]
72. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
[TBL] [Abstract][Full Text] [Related]
73. Chemotherapy and vitamin D supplement use are determinants of serum 25-hydroxyvitamin D levels during the first six months after colorectal cancer diagnosis.
Wesselink E; Bours MJL; de Wilt JHW; Aquarius M; Breukink SO; Hansson B; Keulen ETP; Kok DE; van den Ouweland J; van Roekel EH; Snellen M; Winkels R; Witkamp RF; van Zutphen M; Weijenberg MP; Kampman E; van Duijnhoven FJB
J Steroid Biochem Mol Biol; 2020 May; 199():105577. PubMed ID: 31917319
[TBL] [Abstract][Full Text] [Related]
74. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
75. The association of vitamin D with survival in colorectal cancer patients depends on antioxidant capacity.
Boakye D; Jansen L; Schöttker B; Jansen EHJM; Halama N; Maalmi H; Gào X; Chang-Claude J; Hoffmeister M; Brenner H
Am J Clin Nutr; 2021 Jun; 113(6):1458-1467. PubMed ID: 33740035
[TBL] [Abstract][Full Text] [Related]
76. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies.
Lee JE; Li H; Chan AT; Hollis BW; Lee IM; Stampfer MJ; Wu K; Giovannucci E; Ma J
Cancer Prev Res (Phila); 2011 May; 4(5):735-43. PubMed ID: 21430073
[TBL] [Abstract][Full Text] [Related]
77. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
[TBL] [Abstract][Full Text] [Related]
78. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
79. Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer.
Yuan C; Song M; Zhang Y; Wolpin BM; Meyerhardt JA; Ogino S; Hollis BW; Chan AT; Fuchs CS; Wu K; Wang M; Smith-Warner SA; Giovannucci EL; Ng K
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2323-2331. PubMed ID: 32917664
[TBL] [Abstract][Full Text] [Related]
80. Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.
Bao Y; Ng K; Wolpin BM; Michaud DS; Giovannucci E; Fuchs CS
Br J Cancer; 2010 Apr; 102(9):1422-7. PubMed ID: 20389298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
